Author | Allison C. Rosenthal, DO | OncLive

Author | Allison C. Rosenthal, DO

Articles

Dr. Rosenthal on FDA Approval of Ibrutinib in Marginal Zone Lymphoma

January 20, 2017

Video

Allison C. Rosenthal, DO, hematology consultant, Mayo Clinic, discusses the FDA approval of of ibrutinib (Imbruvica) as a treatment for patients with marginal zone lymphoma (MZL).

Dr. Rosenthal on Treatment Strategies for Indolent Lymphomas

October 20, 2016

Video

Allison C. Rosenthal, DO, hematology consultant, Mayo Clinic, discusses some of the treatment strategies for patients with indolent lymphomas.

x